Luis Ramos, MD
Neurological Surgery · Oldsmar, FLNPI 1699076000
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Organogenesis Inc. at 35.8% of the total. 2025 is the largest year on record at $359, more than ten times the $17 reported in 2020. That places this record below the midpoint for neurological surgery clinicians in FL, where the typical reported total is $5,245.
Across 57 payments — averaging $22.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$464
- Smith+Nephew$246
- Mimedx Group, Inc.$100
- Hydrofera LLC$52
- Convatec Inc.$44
- Surgenex LLC$44
- plus $346 from 14 others
What the payments were for
- Food & beverage$1,296100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 14 | $464 |
| Smith+Nephew | 12 | $246 |
| Mimedx Group, Inc. | 6 | $100 |
| Hydrofera LLC | 3 | $52 |
| Convatec Inc. | 2 | $44 |
| Surgenex LLC | 2 | $44 |
| Kerecis Limited | 3 | $41 |
| Solventum Corporation | 2 | $37 |
| Pfizer | 1 | $34 |
| Bioventus LLC | 1 | $33 |
| AstraZeneca | 1 | $30 |
| Molnlycke Health Care US, LLC | 2 | $29 |
| Medline Industries LP | 1 | $27 |
| KCI USA, Inc. | 1 | $23 |
| Reapplix Inc. | 1 | $20 |
| Acell, Inc. | 1 | $17 |
| Hartmann USA, Inc. | 1 | $15 |
| Evoke Pharma, Inc. | 1 | $14 |
| Almatica Pharma LLC | 1 | $14 |
| Triad Life Sciences Inc. | 1 | $12 |
How this compares
$1,296 in reported general payments places this provider in the 25th percentile of 556 neurological surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 108 | $1,952 |
| Gentamicin Sulfate | 37 | $1,340 |
| Ciprofloxacin Hcl | 92 | $871 |
| Doxycycline Monohydrate | 45 | $834 |
| Doxycycline Hyclate | 36 | $460 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 59 | $334 |
| Cephalexin | 29 | $153 |
| Clindamycin Hcl | 13 | $138 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Oldsmar
- Stephen ParkerJacksonville$18.7M
- Eric PetersonMiami$10.1M
- Brian SnellingBoca Raton$10M
- Kim ManwaringOrlando$5M
- Paul SawinWinter Park$3M
- John MainOcala$2.8M
- Michael WangMiami$2.2M
- Andrew CannestraJacksonville$1.6M
- Rohit VasanTampa$1.5M
- Wilson AsforaMiami$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.